SCHEMBL31070520

SCHEMBL31070520

COc1cc(-c2ccc3c(c2)CNC3)cc(OC)c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.46
NQO2 P16083 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
ACVR1 Q04771 2/20 0.43
ACVR1B P36896 1/20 0.43
TGFBR1 P36897 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
ASIC3 Q9UHC3 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
MEN1 O00255 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
BRD4 O60885 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31070495 0.85 ASIC3 (0.46) CD274ASIC3ALDH1A1CYP3A4TSHR
SCHEMBL31070657 0.77 CHRNB2 (0.48) ADORA1CA12CA1CA2CA9
SCHEMBL31070521 0.73 CD274 (0.63) ADORA1CD274BRD4CYP3A4
SCHEMBL721861 0.73 ACHE (0.65) CA12CA1CA2CA9ALDH1A1
SCHEMBL30040451 0.71 CYP3A4 (0.59) ALDH1A1KDM4ECYP3A4TSHR
SCHEMBL1705264 0.71 CYP3A4 (0.59) ALDH1A1KDM4ECYP3A4TSHR
SCHEMBL17322385 0.71 CA9 (0.51) ADORA1CA12CA1CA2CA9
SCHEMBL3988961 0.70 HSD17B1 (0.56) ADORA1CA12CA1CA2CA9
Hydrochloric Acid SCHEMBL31193341 0.69 CYP3A4 (0.56) ALDH1A1KDM4ECYP3A4TSHR
Hydrochloric Acid SCHEMBL9871800 0.69 CYP3A4 (0.56) ALDH1A1KDM4ECYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118515600-A Isoindoline compound and medical application thereof 中国科学院上海药物研究所 2024-08-20 CN disclosed